Cash-pay patients who want the lowest flat all-in monthly price for compounded GLP-1s and accept that compounded drugs aren't FDA-approved.
- Starting price
- $179/mo all-in
- Consult model
- Video and asynchronous messaging
- Prescriber
- Unconfirmed
- Labs
- Unconfirmed
- Insurance
- Cash pay
- Availability
- Unconfirmed
- Cancellation
- Self-serve online
- Founded
- 2022 · San Francisco, CA
Pricing
Henry's programs page (last updated 2025-12-03) lists flat monthly prices that bundle provider visits, medication, supplies and shipping: $179/mo for compounded liraglutide daily injections or compounded sublingual semaglutide, $249/mo for semaglutide dissolving tablets, $297/mo for compounded semaglutide weekly injections, and $149/mo for phentermine. Discounted 6- and 12-month prepaid plans are also offered. Labs aren't mentioned for weight-management plans.
Prices as listed on October 17, 2026. They change often; confirm at checkout.
What we like
- Flat monthly price published for each plan, bundling visit, medication, supplies and shipping
- Lowest listed GLP-1 plan is $179/mo all-in
- Cancel via the portal, email or phone
- Trustpilot 4.4 from about 12,500 reviews
Watch out for
- GLP-1 options listed are compounded only (not FDA-approved), including oral tirzepatide, which has no approved oral form
- BBB rating F (not accredited; 235 complaints in 3 years)
- Prepaid multi-month plans may require paying the remaining balance if you cancel
- Named in an Eli Lilly false-advertising lawsuit over compounded tirzepatide marketing
Cancelling
Cancel anytime in the patient portal, by email (ask@henrymeds.com) or by phone (909-787-2342). The Terms of Service say to cancel at least 48 hours before renewal; service continues to the end of the paid period. On multi-month plans you 'may be required to pay out the rest of your balance' unless a provider says you can't continue for medical reasons. The $30 consult fee is non-refundable once a prescription is issued, prescription products are final sale, and partially used periods generally aren't refunded.
- 2025-04 Eli Lilly sued Adonis Health (Henry Meds) in N.D. Cal. over marketing of compounded tirzepatide, including oral tirzepatide; in Sept 2025 the court let a narrowed 'personalized' marketing claim proceed and dismissed others. Source ↗
